Suggested Topics within your search.
Suggested Topics within your search.
- English language 55
- Rhetoric 41
- History 31
- Report writing 30
- Management 25
- Grammar 23
- methods 22
- Law 21
- Moral and ethical aspects 18
- Research 18
- College readers 16
- Human anatomy 14
- Philosophy 13
- Handbooks, manuals, etc 12
- Methodology 12
- Problems, exercises, etc 12
- Social conditions 12
- Study and teaching 12
- Politics and government 11
- Academic writing 10
- Leadership 10
- Nursing 10
- Biochemistry 9
- Calculus 9
- Economic development 9
- Human physiology 9
- Mathematics 9
- Policy sciences 9
- Social aspects 9
- Anatomy 8
-
30601
Individualized autoregulation-guided arterial blood pressure management in neurocritical care
Published 2025-01-01Get full text
Article -
30602
The optimal wind speed product selection for wind energy assessment under multi-factor constraints
Published 2025-02-01Get full text
Article -
30603
Assessment of the variability and correlation of biometric measurements in eyes with cataracts
Published 2025-02-01Get full text
Article -
30604
Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
Published 2025-02-01“…Kara Grimes,1,* Chisom T Madu,2 Carena Carrington,3 Daniel Laroche4,5,* 1School of Medicine, New York Medical College, Valhalla, NY, USA; 2School of Medicine, City University of New York School of Medicine, New Yorkṭ, NY, USA; 3School of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA; 4Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA; 5Advanced Eye Care of New York, New York, NY, USA*These authors contributed equally to this workCorrespondence: Daniel Laroche, Advanced Eye Care of New York, 49 West 127th Street, New York, NY, 10027, USA, Tel +1-212-663-0473, Email dlarochemd@aol.comPurpose: To assess the validity of a novel, low-cost glaucoma screening calculator in determining glaucoma risk in high-risk New York communities.Patients and Methods: This prognostic community-based study was conducted in New York City neighborhoods from 2022 to 2024 among participants aged 40 years and older. …”
Get full text
Article -
30605
-
30606
-
30607
-
30608
-
30609
-
30610
-
30611
-
30612
-
30613
-
30614
-
30615
-
30616
-
30617
-
30618
-
30619
-
30620